ProKidney
ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease, with the potential to preserve kidney function and change patients’ lives.

Year Established: 2015
Stock Ticker: PROK
Exchange: NASDAQ